Hypodermite sous inhibiteur de BRAF et/ou inhibiteur de MEK : revue de la littérature à partir d’une nouvelle observation
- 15 September 2020
- journal article
- review article
- Published by Elsevier BV in Annales de Dermatologie et de Vénéréologie
- Vol. 147 (12), 833-841
- https://doi.org/10.1016/j.annder.2020.07.013
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Panniculitis in Patients Treated With BRAF InhibitorsThe American Journal of Dermatopathology, 2014
- Vemurafenib-Induced Neutrophilic Panniculitis in a Child with a Brainstem GliomaPediatric Dermatology, 2014
- BRAF inhibitors‐induced panniculitis: a cutaneous side effect mimicking subcutaneous melanoma metastasisJournal of the European Academy of Dermatology and Venereology, 2014
- Erythema Nodosum–Like Panniculitis in Patients With Melanoma Treated With VemurafenibJournal of Clinical Oncology, 2013
- Neutrophilic panniculitis developing after treatment of metastatic melanoma with vemurafenibJournal of Cutaneous Pathology, 2013
- BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic MelanomaClinical Cancer Research, 2013
- Vasculitis and panniculitis associated with vemurafenibJournal of the American Academy of Dermatology, 2012
- Vemurafenib-induced neutrophilic panniculitisMelanoma Research, 2012
- Panniculitis With Arthralgia in Patients With Melanoma Treated With Selective BRAF Inhibitors and Its ManagementArchives of Dermatology, 2012
- Melanophagic Dermatitis and Panniculitis A Condition Revealing an Occult Metastatic Malignant MelanomaThe American Journal of Dermatopathology, 1988